Furthermore, IL-2 cytokine stripped from the membrane of NRP+I led to the activation of intratumoral cytotoxic T cells (CTLs) in the tumor microenvironment, which resulted in the synergistic effect of chemo-immunotherapy (Figure 11) [141]. The gene discussed is IL2; the disease is neoplasm.